Impaired myelination and reduced ferric iron in mucolipidosis IV brain
Mucolipidosis type IV (MLIV) is a lysosomal storage disease caused by mutations in the MCOLN1 gene, which encodes the lysosomal transient receptor potential ion channel mucolipin-1 (TRPML1). MLIV causes impaired motor and cognitive development, progressive loss of vision and gastric achlorhydria. Ho...
Gespeichert in:
Veröffentlicht in: | Disease models & mechanisms 2015-01 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Mucolipidosis type IV (MLIV) is a lysosomal storage disease caused by mutations in the MCOLN1 gene, which encodes the lysosomal transient receptor potential ion channel mucolipin-1 (TRPML1). MLIV causes impaired motor and cognitive development, progressive loss of vision and gastric achlorhydria. How loss of TRPML1 leads to severe psychomotor retardation is currently unknown and there is no therapy for MLIV. White matter abnormalities and a hypoplastic corpus callosum are the major hallmarks of MLIV brain pathology. Here we report that loss of TRPML1 in mice results in developmental aberrations of brain myelination due to deficient maturation and loss of oligodendrocytes. Defective myelination is evident in Mcoln1−/− mice at post-natal day 10, an active stage of post-natal myelination in the mouse brain. Expression of mature oligodendrocyte markers is reduced in Mcoln1−/− mice at post-natal day 10 and remains lower throughout the course of disease. We observed reduced Perls’ staining in Mcoln1−/− brain indicating lower levels of ferric iron. Total iron content in unperfused brain is not significantly different between Mcoln1−/− and wild-type littermate mice, suggesting that the observed maturation delay or loss of oligodendrocytes may be caused by impaired iron handling, rather than global iron deficiency. Overall, these data emphasize a developmental rather than a degenerative disease course in MLIV, and argue for a stronger focus on oligodendrocyte maturation and survival in the search for answers to MLIV pathogenesis and treatment. |
---|---|
ISSN: | 1754-8403 1754-8411 |
DOI: | 10.1242/dmm.021154 |